Episode
Episode 156: Immune Thrombocytopenic Purpura Series, Pt 2- Relapsed/Refractory
- Published
- Jun 24, 2026
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This week, we move to the relapsed/refractory ITP setting, focusing on what options are available to patients after their initial treatment with steroids ± IVIg, which we discussed in Episode 155. If you have not done so already, definitely listen to that episode as we build on the topics discussed here today! Content: - What are options after steroids? - How to counsel patients on options? - Is there a correct way to sequence available options? ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Youtube